不过它的估值比礼来便宜,也许值得定投。
减肥药第二梯队如VKTX CRBP 值得关注,可能成为并购对象。
谁当选对板块影响不大,国会属于哪个党也许更要紧。
不过它的估值比礼来便宜,也许值得定投。
减肥药第二梯队如VKTX CRBP 值得关注,可能成为并购对象。
谁当选对板块影响不大,国会属于哪个党也许更要紧。
WENXUECITY.COM does not represent or guarantee the truthfulness, accuracy, or reliability of any of communications posted by other users.
Copyright ©1998-2025 wenxuecity.com All rights reserved. Privacy Statement & Terms of Use & User Privacy Protection Policy